Synergism Antiproliferative Effects of Apigenin and Naringenin in NSCLC Cells.
Xiongxiong LiuTing ZhaoZheng ShiCuilan HuQiang LiChao SunPublished in: Molecules (Basel, Switzerland) (2023)
Non-small cell lung cancer (NSCLC) is one of the leading cancer killers. Apigenin (Api) and Naringenin (Nar) are natural bioactive substances obtained in various vegetables and fruits, possessing anti-tumor effects across multiple studies. This study investigated the latent synergistic antiproliferative functions of Api and Nar in A549 and H1299 NSCLC cells. Cell viability was determined after incubating with different concentrations of Api, Nar, or the combination of Api and Nar (CoAN) for 24 h. Analysis using the CompuSyn software revealed that the CI value of each combined dose was < 1, depicting that the two drugs had a synergistic inhibitory effect. The CoAN (A:N = 3:2) group with the lowest CI value was selected for subsequent experiments. The IC 50 of CoAN (A:N = 3:2) was used to determine the cell cycle, the expression ratio of Bax to Bcl2, Caspase 3 activity, and mitochondrial function to assess oxidative stress and apoptosis. The results established that CoAN treatment caused significant cytotoxicity with cell cycle arrest at G2/M phases. Furthermore, CoAN significantly enhanced mitochondria dysfunction, elevated oxidative stress, and activated the apoptotic pathway versus Api or Nar alone groups. Thus, the CoAN chemotherapy approach is promising and deserves further research.
Keyphrases
- cell cycle arrest
- cell death
- oxidative stress
- induced apoptosis
- cell cycle
- small cell lung cancer
- pi k akt
- endoplasmic reticulum stress
- cell proliferation
- advanced non small cell lung cancer
- signaling pathway
- dna damage
- ischemia reperfusion injury
- diabetic rats
- poor prognosis
- cancer therapy
- drinking water
- reactive oxygen species
- climate change
- single cell
- drug delivery
- squamous cell carcinoma
- locally advanced
- smoking cessation
- replacement therapy
- anti inflammatory